298 related articles for article (PubMed ID: 21295012)
1. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
Lin WW; Hsieh SL
Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
[TBL] [Abstract][Full Text] [Related]
2. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.
Hsieh SL; Lin WW
J Biomed Sci; 2017 Jun; 24(1):39. PubMed ID: 28629361
[TBL] [Abstract][Full Text] [Related]
3. DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression.
Zhang H; Chen X; Li D; Cui L; Li X; Ye X; Wan X
Oncol Rep; 2017 Jul; 38(1):377-383. PubMed ID: 28560426
[TBL] [Abstract][Full Text] [Related]
4. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
5. High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis.
Bamias G; Kaltsa G; Siakavellas SI; Papaxoinis K; Zampeli E; Michopoulos S; Zouboulis-Vafiadis I; Ladas SD
Clin Immunol; 2010 Nov; 137(2):242-9. PubMed ID: 20675196
[TBL] [Abstract][Full Text] [Related]
6. Functional characterisation of decoy receptor 3 in Crohn's disease.
Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
[TBL] [Abstract][Full Text] [Related]
7. DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts.
Takahashi M; Miura Y; Hayashi S; Tateishi K; Fukuda K; Kurosaka M
Int J Mol Med; 2011 Sep; 28(3):423-7. PubMed ID: 21537832
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis.
Bamias G; Siakavellas SI; Stamatelopoulos KS; Chryssochoou E; Papamichael C; Sfikakis PP
Clin Immunol; 2008 Nov; 129(2):249-55. PubMed ID: 18757243
[TBL] [Abstract][Full Text] [Related]
9. Decoy receptor 3 protects non-obese diabetic mice from autoimmune diabetes by regulating dendritic cell maturation and function.
Wang YL; Chou FC; Sung HH; Fan PL; Hsueh CW; Lin WC; Chen SJ; Lin WW; Sytwu HK
Mol Immunol; 2010 Oct; 47(16):2552-62. PubMed ID: 20801512
[TBL] [Abstract][Full Text] [Related]
10. The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases.
Siakavellas SI; Sfikakis PP; Bamias G
Semin Arthritis Rheum; 2015 Aug; 45(1):1-8. PubMed ID: 25887448
[TBL] [Abstract][Full Text] [Related]
11. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M
Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906
[TBL] [Abstract][Full Text] [Related]
12. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions.
Bamias G; Evangelou K; Vergou T; Tsimaratou K; Kaltsa G; Antoniou C; Kotsinas A; Kim S; Gorgoulis V; Stratigos AJ; Sfikakis PP
Exp Dermatol; 2011 Sep; 20(9):725-31. PubMed ID: 21672030
[TBL] [Abstract][Full Text] [Related]
13. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
Chang PM; Chen PM; Hsieh SL; Tzeng CH; Liu JH; Chiou TJ; Wang WS; Yen CC; Gau JP; Yang MH
Int J Oncol; 2008 Sep; 33(3):549-54. PubMed ID: 18695885
[TBL] [Abstract][Full Text] [Related]
14. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.
Mueller AM; Pedré X; Killian S; David M; Steinbrecher A
J Neuroimmunol; 2009 Apr; 209(1-2):57-64. PubMed ID: 19269042
[TBL] [Abstract][Full Text] [Related]
15. DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression.
Han B; Wu J
J Immunol; 2009 Dec; 183(12):8157-66. PubMed ID: 20007581
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of the TL1A/DcR3 system of TNF/TNFR-like proteins in large vs. small intestinal Crohn's disease.
Bamias G; Kaltsa G; Siakavellas SI; Gizis M; Margantinis G; Zampeli E; Vafiadis-Zoumboulis I; Michopoulos S; Daikos GL; Ladas SD
Dig Liver Dis; 2012 Jan; 44(1):30-6. PubMed ID: 21978578
[TBL] [Abstract][Full Text] [Related]
17. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.
Connor JP; Felder M
Gynecol Oncol; 2008 Nov; 111(2):330-5. PubMed ID: 18723214
[TBL] [Abstract][Full Text] [Related]
18. Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages.
Tai SK; Chang HC; Lan KL; Lee CT; Yang CY; Chen NJ; Chou TY; Tarng DC; Hsieh SL
J Immunol; 2012 Mar; 188(5):2464-71. PubMed ID: 22287720
[TBL] [Abstract][Full Text] [Related]
19. EGFR-driven up-regulation of decoy receptor 3 in keratinocytes contributes to the pathogenesis of psoriasis.
Wu NL; Huang DY; Hsieh SL; Hsiao CH; Lee TA; Lin WW
Biochim Biophys Acta; 2013 Oct; 1832(10):1538-48. PubMed ID: 23707413
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and preliminary expression analysis of banded dogfish (Triakis scyllia) TNF decoy receptor 3 (TNFRSF6B).
Inoue Y; Morinaga A; Takizawa F; Saito T; Endo M; Haruta C; Nakai T; Moritomo T; Nakanishi T
Fish Shellfish Immunol; 2008 Mar; 24(3):360-5. PubMed ID: 18201904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
